Doctor profile · Federal record
Dr. Robert Kaplan, MD
Dermatology Physician (CMS: General Practice) · Memphis, TN
- NPI 1750359543
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 53 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
6401 Poplar Ave, Suite 330
Memphis, TN 381194806
(901) 682-3273
fax (901) 682-6559
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- December 11, 2014
- Year of graduation
- 1973 — 53 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Tennessee #8281
- Medicaid
- TN #3162895
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1750359543. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,360
Distinct HCPCS
10
Medicare allowed
$575,403
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
11103 |
Biopsy of related skin growth, each additional growth | 3,221 | 751 | $46 | |
11102 |
Biopsy of related skin growth, first growth | 1,631 | 852 | $85 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,372 | 659 | $82 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,054 | 105 | $1 | |
J1030 |
Injection, methylprednisolone acetate, 40 mg | 532 | 104 | $7 | |
11901 |
Injection into skin growth, more than 7 growths | 462 | 188 | $52 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 388 | 281 | $117 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 113 | 82 | $131 | |
17282 |
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | 81 | 54 | $173 | |
17281 |
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 77 | 55 | $130 |
In context: peer comparison
Among 5 peers in Memphis Dermatology Physician, average services per provider: 314. This provider delivers 30× the peer median.Open Payments
Industry payments received
All-time total
$1,326
Transactions
68
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | 9 | $336.88 | |
| Dermavant Sciences, INC. | 14 | $228.39 | |
| E.R. Squibb & Sons, L.L.C. | 17 | $146.01 | |
| Janssen Scientific Affairs, LLC | 1 | $137.73 | |
| Novartis Pharmaceuticals Corporation | 9 | $134.03 | |
| Janssen Biotech, INC. | 6 | $81.69 | |
| Genzyme Corporation | 4 | $80.07 | |
| Lilly USA, LLC | 2 | $59.09 | |
| Abbvie INC. | 3 | $55.27 | |
| Ucb, INC. | 1 | $23.59 | |
| Arcutis Biotherapeutics, INC. | 1 | $23.03 | |
| Pfizer INC. | 1 | $20.20 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,953
Patients
1,158
Total drug cost
$49,633
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Mupirocin | Generic | 429 | 300 | $3,872 |
| Betamethasone Valerate | Generic | 273 | 139 | $11,898 |
| Ketoconazole | Generic | 262 | 126 | $5,142 |
| Cephalexin | Generic | 231 | 144 | $2,385 |
| Mometasone Furoate | Generic | 141 | 88 | $4,651 |
| Fluocinonide | Generic | 128 | 73 | $10,967 |
| Prednisone | Generic | 106 | 70 | $288 |
| Hydrocortisone | Generic | 103 | 54 | $1,149 |
| Triamcinolone Acetonide | Generic | 91 | 52 | $1,622 |
| Clobetasol Propionate | Generic | 44 | 28 | $3,450 |
Frequently asked questions
What is Dr. Robert Kaplan's medical specialty?
Dr. Robert Kaplan practices Dermatology Physician in Memphis, TN.
Where does Dr. Robert Kaplan practice?
Dr. Robert Kaplan practices at 6401 Poplar Ave, Memphis, TN 381194806. Office phone: 9016823273.
What is Dr. Robert Kaplan's NPI?
Dr. Robert Kaplan's National Provider Identifier (NPI) is 1750359543, issued by NPPES.
Does Dr. Robert Kaplan accept Medicare assignment?
Yes. Dr. Robert Kaplan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Robert Kaplan commonly perform?
Top Medicare-reported procedures in 2023: Biopsy of related skin growth, each additional growth (HCPCS 11103); Biopsy of related skin growth, first growth (HCPCS 11102); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.